Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers.

A cross-sectional study of cerebral blood flow (CBF) levels in 268 neurologically normal volunteers contrasting nonsmokers, smokers who quit, and current cigarette smokers indicated that subjects who quit smoking had significantly higher cerebral perfusion levels than subjects who had continued to smoke but remained lower than subjects without a history of cigarette smoking. All subjects were matched for age and sex, and smoking groups were matched for duration and amount of smoking. A prospective study of 11 subjects who were able to stop smoking in which CBF levels were available both antecedent to and following cessation of the habit indicated that significant gains occurred in cerebral perfusion levels within one year following cessation of smoking. A control group of 22 subjects who continued to smoke (matched for age, sex, duration of smoking, and duration of time between baseline and follow-up) showed no change in CBF values. A correlation between magnitude of CBF change and duration of cessation of cigarette smoking demonstrated a significant linear increase in CBF during the one-year period. These results suggest that elderly individuals who have smoked for three to four decades can benefit substantially by abstaining from cigarette smoking and that significant improvement in cerebral circulation occurs within a relatively short period.

[1]  A. Ostfeld,et al.  Smoking and coronary heart disease mortality in the elderly. , 1984, JAMA.

[2]  R. L. Rogers,et al.  Progressive cerebral ischemia antedates cerebrovascular symptoms by two years , 1984, Annals of neurology.

[3]  R. L. Rogers,et al.  Cerebral blood flow changes in benign aging and cerebrovascular disease , 1984, Neurology.

[4]  R. L. Rogers,et al.  The Effects of Chronic Cigarette Smoking on Cerebrovascular Responsiveness to 5 Per Cent CO2 and 100 Per Cent O2 Inhalation , 1984, Journal of the American Geriatrics Society.

[5]  H. Kato,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. , 1984, Stroke.

[6]  R. L. Rogers,et al.  Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. , 1983, JAMA.

[7]  Å. Wennmalm.  Interaction of nicotine and prostaglandins in the cardiovascular system. , 1982, Prostaglandins.

[8]  D. Petitti,et al.  Mortality in cigarette smokers and quitters. Effect of base-line differences. , 1981, The New England journal of medicine.

[9]  P. Alster,et al.  Effect of nicotine on the formation of prostaglandins in the rabbit kidney. , 1981, Acta physiologica Scandinavica. Supplementum.

[10]  Å. Wennmalm,et al.  INHIBITION BY NICOTINE OF THE FORMATION OF PROSTACYCLIN‐LIKE ACTIVITY IN RABBIT AND HUMAN VASCULAR TISSUE , 1980, British journal of pharmacology.

[11]  S Moncada,et al.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. , 1979, The New England journal of medicine.

[12]  H. Mcgill.  Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. , 1979, Preventive medicine.

[13]  F. Sakai,et al.  Regional cerebral blood flow, diaschisis, and steal after stroke. , 1979, Neurological research.

[14]  J. Strain,et al.  Screening for organic mental syndromes in the medically ill. , 1977, Annals of internal medicine.

[15]  C. Seltzer.  Smoking and coronary heart disease in the elderly , 1975, The American journal of the medical sciences.

[16]  W. Kannel,et al.  Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.

[17]  W. Kannel,et al.  THE RELATIONSHIP OF CIGARETTE SMOKING TO CORONARY HEART DISEASE; THE SECOND REPORT OF THE COMBINED EXPERIENCE OF THE ALBANY, NY. AND FRAMINGHAM, MASS. STUDIES. , 1964, JAMA.